Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Gore Range Capital

Gore Range Capital
VC INVESTOR TYPE
Active STATUS
6 PROFESSIONALS
15 INVESTMENTS
10 PORTFOLIO
4 EXITS
Description

Founded in 2015, Gore Range Capital is a venture capital firm based in New York, New York. The firm focuses on early and growth-stage healthcare businesses where it offers insights as well as operational, clinical and scientific expertise in addition to capital financing.

Investor Status
Actively Seeking New Investments
Year Founded
2015
Primary Investor Type
Venture Capital
Primary Office
  • 767 Third Avenue
  • 7th Floor
  • New York, NY 10017
  • United States

Gore Range Capital Investments (15)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Castle Biosciences 18-Mar-2019 Later Stage VC 0000 Laboratory Services (Healthcare) Profitable 00000 00000
000 00000000000 29-Oct-2018 00000 00000 00000 Therapeutic Devices Generating Revenue/Not Profitable 00000 00000
00000000 000000000 01-Oct-2018 00000 00000 Laboratory Services (Healthcare) Generating Revenue 0000 00000000
000000 0000000 01-Oct-2017 00000 00000 000.00 Surgical Devices Generating Revenue
00-00000 000000000 20-Sep-2017 00000 00000 Drug Discovery Generating Revenue 00000 00000
00000000 000000 17-May-2017 00000 00000 000 Other Healthcare Services Generating Revenue
0000000 13-Feb-2017 0000 00000 00.00 Medical Records Systems Generating Revenue 00000 00000
00000000 0000000 03-Feb-2017 0000 00000 Other Devices and Supplies Generating Revenue 00000 00000000000
Rhamnopharma 09-Sep-2016 Early Stage VC Biotechnology Out of Business
CoreMedica 25-Aug-2016 Early Stage VC 00.00 Laboratory Services (Healthcare) Generating Revenue 00000 00000
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Gore Range Capital’s full profile, request a free trial.

Gore Range Capital Exits (4)

Company Name Exit Date Exit Type Exit Size Status Buyers
Castle Biosciences 25-Jul-2019 IPO 0000 Completed
000000 0000000 02-Aug-2018 000000000000000000 00000 Completed
  • 000000 0000000000
BioXcel Therapeutics 08-Mar-2018 IPO 0000 Completed
Rhamnopharma Out of Business Completed
To view this investor’s complete exits history, request access »

Gore Range Capital Team (11)

Name Title Deals Funds Boards Office Contact
Info
Ethan Rigel Founder & Managing Partner 0 0 0 New York, NY
Frank DeBernardis Founding & Operating Partner 0 0 New York, NY
Humberto Antunes Partner 0 0 New York, NY
Ellen Yang Senior Associate New York, NY
Darrell Rigel Advisor New York, NY

1 Former Team Member

You’re viewing 5 of 11 team members. Get the full list »